BeOne Medicines Ltd
268 hedge funds and large institutions have $19.1B invested in BeOne Medicines Ltd in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 109 increasing their positions, 77 reducing their positions, and 17 closing their positions.
100% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 17
42% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 77
6% more funds holding
Funds holding: 253 → 268 (+15)
0.09% less ownership
Funds ownership: 4.74% → 4.65% (-0.09%)
2% less capital invested
Capital invested by funds: $19.5B → $19.1B (-$455M)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
44% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $18.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$47.2M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$46.8M |
| 3 |
Morgan Stanley
New York
|
+$25.5M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$24.1M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$83.8M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$51.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$49M |
| 4 |
Nomura Asset Management
Tokyo,
Japan
|
-$47.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$41.7M |
ONC Hedge Fund Activity: Q2 2021 in Review
268 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2021, worth a combined $19.1B — down 2.3% from $19.5B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ONC positions and 17 closed out — a net gain of 17 holders — while 109 added to existing stakes and 77 trimmed.
The largest buyer was Capital International Investors, adding an estimated $47.2M. The largest seller was Wellington Management Group, cutting an estimated $83.8M.
- 268 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2021, up from 253 in Q1 2021.
- Funds reported $19.1B of BeOne Medicines Ltd stock for Q2 2021, down 2.3% quarter-over-quarter.
- 34 funds opened new BeOne Medicines Ltd positions in Q2 2021 and 17 closed out, a net change of +17 holders.
- The largest BeOne Medicines Ltd buyer in Q2 2021 was Capital International Investors, an estimated $47.2M added.
- The largest BeOne Medicines Ltd seller in Q2 2021 was Wellington Management Group, an estimated $83.8M sold.
Based on aggregated 13F filings for Q2 2021.